Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Not yet recruiting 2Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Thoracic 1Head & Neck 1Breast 1

Conditions

Hematologic Neoplasms 2Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Leukemia 1

Interventions

Cytarabine 465Cyclophosphamide 459fludarabine phosphate 277Rituximab 249Methotrexate 245Etoposide 203fludarabine 200Filgrastim 199Peripheral Blood Stem Cell Transplantation 180Busulfan 169Vincristine 163Dexamethasone 153Daunorubicin 151Azacitidine 145Mycophenolic Acid 142Whole-Body Irradiation 133Tacrolimus 127Imatinib Mesylate 127Cyclosporine 123Granulocyte Colony-Stimulating Factor 118Radiotherapy 113Melphalan 110Idarubicin 103Doxorubicin 101Mitoxantrone 97Decitabine 97Antilymphocyte Serum 97Lenalidomide 96Mercaptopurine 93Prednisone 91

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Blood Cell Count × Other hematologic neoplasm × Clear all
NCT06369662 2024-10-16

CD155 Expression in Acute Myeloid Leukemia

Assiut University

Completed
93 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04454723 2024-03-05

PalliaQOL

University of Oklahoma

Phase NA Completed
20 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡